Atıf İçin Kopyala
Yamamoto-Furusho J. K., Al Harbi O., Armuzzi A., Chan W., de Leon E. P., Qian J., ...Daha Fazla
DIGESTIVE AND LIVER DISEASE, cilt.52, sa.8, ss.869-877, 2020 (SCI-Expanded)
-
Yayın Türü:
Makale / Tam Makale
-
Cilt numarası:
52
Sayı:
8
-
Basım Tarihi:
2020
-
Doi Numarası:
10.1016/j.dld.2020.05.031
-
Dergi Adı:
DIGESTIVE AND LIVER DISEASE
-
Derginin Tarandığı İndeksler:
Science Citation Index Expanded (SCI-EXPANDED), Scopus, BIOSIS, EMBASE, MEDLINE
-
Sayfa Sayıları:
ss.869-877
-
Anahtar Kelimeler:
Ulcerative colitis, Crohn's disease, Anti-tumor necrosis factor, Suboptimal response, TAIWAN CONSENSUS GUIDELINE, ANTI-TNF THERAPY, ULCERATIVE-COLITIS, INDUCTION THERAPY, MANAGEMENT, CROHNS, ADALIMUMAB, INFLIXIMAB, SOCIETY, IBD
-
Ankara Üniversitesi Adresli:
Evet
Özet
Background: Incidence of inflammatory bowel disease (IBD) is increasing in newly industrialised countries (NICs); however, data on suboptimal response to anti-tumor necrosis factor (anti-TNF) agents are limited.